FDA Center for Drug Evaluation & Research Issues Warning Letter to Dabur India
August 05, 2026
August 05, 2026
WASHINGTON, Aug. 5 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Dabur India Limited from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Mohit Malhotra, Chief Executive Officer, Dabur India Limited, Dabur Corporate Office, Kaushambi, Sahibabad, Ghaziabad 201010, India
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
Warning . . .
* * *
Recipient: Mr. Mohit Malhotra, Chief Executive Officer, Dabur India Limited, Dabur Corporate Office, Kaushambi, Sahibabad, Ghaziabad 201010, India
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
Warning . . .